palmitoylethanolamide.com.au
HomeResearchFriederike 2021

Hair endocannabinoid concentrations in individuals with acute and weight-recovered anorexia nervosa

Friederike I Tam, Julius Steding, Jonas L Steinhäuser, Franziska Ritschel, Wei Gao, Kerstin Weidner, Veit Roessner, Clemens Kirschbaum, Stefan Ehrlich. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Apr 20:107:110243.

Observational studyHumans

Design
Observational study
Subjects
67 underweight female patients with acute anorexia nervosa (47 reassessed after short-term weight restoration), 27 long-term recovered patients and 84 healthy controls
Dose used in the study
Not applicable; palmitoylethanolamide was measured in hair, not given
Duration
Cross-sectional with a longitudinal reassessment after a BMI increase of at least 14%
What was measured
Hair concentrations of anandamide, 2-AG, palmitoylethanolamide, oleoylethanolamide and stearoylethanolamide.

What the authors reported

Anandamide and all endocannabinoid-related compounds, including palmitoylethanolamide, were elevated in acute anorexia and fell with short-term weight restoration. Anandamide stayed elevated in long-term recovered patients, and in recovered patients physical activity correlated positively with all the related compounds.

Limits of this study

An observational study of the body's own PEA in hair; it did not test PEA treatment and cannot show cause. Funding and conflicts not stated in the abstract.

Source

PubMed 33444649 · doi:10.1016/j.pnpbp.2021.110243

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.